









This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: 10.1111/imm.12980 
This article is protected by copyright. All rights reserved. 
DR. MARÍA VIRGINIA TRIBULATTI (Orcid ID : 0000-0003-0507-065X) 
 
Article type      : Original Article 
 
 
Title: Interleukin-6 signaling mediates Galectin-8 costimulatory activity of antigen-specific 
CD4 T cell response 
 
Short Title: Galectin-8 induces IL-6 secretion and signaling  
 
Julieta Carabelli1*; Cecilia Arahí Prato1*; Liliana María Sanmarco2,3; Maria Pilar Aoki2,3; 
Oscar Campetella1# and María Virginia Tribulatti1#& 
1 Laboratorio de Inmunología Molecular, Instituto de Investigaciones Biotecnológicas, 
Universidad Nacional de San Martín (UNSAM), Consejo Nacional de Investigaciones 
Científicas y Técnicas (CONICET), San Martín, Buenos Aires, Argentina; 2 Universidad 
Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica. 
Córdoba, Argentina.3 Consejo Nacional de Investigaciones Científicas y Tecnológicas 
(CONICET), Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), 
Córdoba, Argentina. 
 
*Julieta Carabelli and Cecilia Arahí Prato should be considered joint first author. 
#Oscar Campetella and María Virginia Tribulatti should be considered joint senior author. 
 
&Correspondence: Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San 
Martín, Campus Miguelete, Avenida 25 de Mayo y Francia, San Martín, Buenos Aires 











This article is protected by copyright. All rights reserved. 




APC: antigen-presenting cell  
BMDC: bone marrow-derived dendritic cell 
DC: dendritic cell 
FMDV: Foot-and-Mouth-Disease virus  
Gal: galectin 
IL-6: interleukin-6 
IL-6R: interleukin-6 receptor 
KO: knock out 
OVA: ovoalbumin 
Tfh: follicular helper T cell 
WT: wild type 
 
Abstract 
Galectin-8 (Gal-8) is a mammalian lectin endowed with the ability to costimulate antigen-
specific immune responses. We have previously demonstrated that bone marrow-derived 
dendritic cells produce high levels of IL-6 in response to Gal-8 stimulation. Since IL-6 is a 
pleiotropic cytokine that has a broad effect on cells of the immune system, in the present 
study we aimed to elucidate whether IL-6 was involved in Gal-8-dependent costimulatory 
signals during antigen recognition by specific CD4 T cells. To this aim, splenocytes from 
DO11.10 mice were incubated with a low dose of the cognate ovoalbumin peptide in 
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Gal-8 alone or Gal-8 plus cognate peptide. Moreover, IL-6 signaling was triggered during 
Gal-8-induced costimulation as determined by phosphorylation of STAT3. IL-6 blockade by 
neutralizing monoclonal antibody precluded Gal-8 costimulatory activity but did not affect 
the antigen-specific TCR activation. Different subsets of dendritic cells, as well as 
macrophages and B cells, were identified as the cellular source of IL-6 during Gal-8-induced 
costimulation. To confirm that IL-6 mediated the Gal-8 costimulatory effect, antigen-
presenting cells from IL-6-deficient or wild-type mice were co-cultured with purified CD4 T 
cells from OTII mice in the presence of cognate peptide and Gal-8. Notably, Gal-8-induced 
costimulation but not the antigen-specific response, was significantly impaired in the 
presence of IL-6-deficient antigen-presenting cells. Even more, exogenous IL-6 fully restored 
Gal-8-induced costimulation. Taken together, our results demonstrate that IL-6 signaling 
mediates the Gal-8 immune-stimulatory effect. 
 
Introduction 
Galectins (Gals) constitute a family of mammalian lectins characterized by the presence 
of conserved carbohydrate-recognition domains (CRDs) that bind to N-acetyl-lactosamine-
containing glycans on target cells. Several studies positioned Gals as cue mediators of the 
immune response since they are implicated in many different processes such as tumor escape, 
autoimmunity disorders, tolerance induction and host defense 1, 2. Our group previously 
demonstrated that Gal-8 has a predominant activating role in the elicitation of primary 
adaptive immune response 3-5. We found that Gal-8 costimulate borderline antigen-specific T 
cell responses by synergizing the TCR-specific signaling in the presence of a low dose of the 
antigen. From a mechanistic view, Gal-8 strengthens TCR signaling through activation of the 
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Although CD4 T cells were identified as target cells of the Gal-8 costimulatory effect, 
the simultaneous presence of antigen-presenting cells (APCs) and the antigen is required to 
reach the Gal booster of the T cell activation 4. This observation unveils a role for Gal-8 on 
the cooperative link between APCs and CD4 T cells during antigen presentation. In line with 
this, we have recently reported that Gal-8 induces full activation of mouse bone marrow-
derived dendritic cells (BMDCs) and splenic dendritic cells (DCs), which may represent one 
of the mechanisms involved in the elicitation of the adaptive immune response previously 
observed. Indeed, Gal-8-stimulated DCs evidenced an increased expression of MHCII, CD80 
and CD86 molecules, an augmented capacity to activate antigen-specific T cell responses, 
and a strong production of IL-6, among other inflammatory cytokines 5. 
IL-6 is a pleiotropic cytokine that provides key early signals to shape innate immune 
response 6, CD4 and CD8 T cell effector responses, as well as memory formation 7-13. In 
particular, IL-6 has been identified as a key driver of follicular helper T (Tfh) cell 
differentiation, which support high affinity antibody production by germinal center B cells14-
16. At molecular level, IL-6 positively regulates cathepsin S expression in DCs, which leads 
to a more diverse repertoire of Tfh cells 17. Recently, Brahmakshatriya et al 18 demonstrated 
that high levels of IL-6 directly delivered from TLR-pre-activated DCs are a central factor for 
generating optimal helper T cell responses that drives an effective humoral immunity in aged 
mice. In this regard, we have recently demonstrated that a single dose of inactivated Foot-
and-Mouth-Disease virus (FMDV) formulated with soluble Gal-8 triggers a neutralizing 
humoral response that enhanced protection against homologous viral challenge. Remarkably, 
the Gal-8-induced anti-FMDV response was preceded by a peak of IL-6 and IFN-γ 
production at 48 h post-immunization, which returned to basal levels at day 5 after 
immunization, suggesting that Gal-8 circumscribed its effects to the very beginning of the 
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which is crucial for the rapid anti-FMDV antibody response 19, we postulated that Gal-8-
induced DC-derived IL-6 could be involved in the stimulation of humoral response in the 
FMDV experimental model. 
Despite the accumulating data regarding IL-6 production during the immune-
stimulatory activity exerted by Gal-8, the actual involvement of IL-6 in the Gal-8-induced 




C57BL/6J, C.Cg-Tg(DO11.10)10Dlo/J (DO11.10), B6.Cg-Tg(TcraTcrb)425Cbn/J (OTII) 
and B6.129S2-Il6tm1Kopf/J (IL6KO) breeding pairs were obtained from The Jackson 
Laboratory (Bar Harbor, ME, USA) and bred in our facilities. The Ethical Committee Boards 




Recombinant Gal-8 was obtained as described previously 5. Briefly, Gal-8L mouse isoform 
(GenBankEF524570) was expressed in Escherichia coli BL-21 and purified by Lactosyl-
Sepharose (Sigma-Aldrich, St. Louis, MO, USA) followed by immobilized metal affinity 
chromatography. Lectin activity was tested by hemagglutination as reported elsewhere 20. 
 
Splenocytes and CD4+ T cell purification or depletion 
Mouse splenocytes were obtained as described previously 4. For CD4+ T cell purification, 
MojoSort Mouse CD4 Naïve Cell Untouched Isolation kit was used, following the 
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checked by flow cytometry. For CD4 T cell depletion, MiniMacs columns and anti-CD4-
coupled paramagnetic particles (Miltenyi Biotec, Auburn, CA, USA) were used, following 
the manufacturer’s instructions. Depletion was confirmed by flow cytometry. 
 
Costimulation assays 
For costimulatory assays, splenocytes (3x105 cells) from DO11.10 mice were cultured for 48 
h at 37˚C in 5% CO2 in flat-bottom, 96-well plates in 0.2 ml RPMI 1640 medium (Thermo 
Fisher Scientific, Waltham, MA, USA), in the presence of 10% FCS (Gibco, Thermo Fisher 
Scientific, Massachusetts, USA), 2 mM glutamine, and 5 mg/ml Gentamicin (complete 
medium), in the presence of the cognate OVA323–339 peptide (Genscript, Piscataway, NJ, 
USA) at the indicated concentrations and 0.2 μM of recombinant Gal-8. For IL-6 
neutralization, 2 μg/ml of IL-6 neutralizing monoclonal antibody (Clone: MP5-20F3) or 
matching isotype control (Biolegend) were used. Two different approaches were carried out 
to obtain IL6KO and C57BL/6J mice-derived APCs. For Mitomycin-APCs, splenocytes 
were pretreated with 200 mg/ml Mitomycin C (Sigma) in RPMI 1640 media for 1 h on ice, 
and cells were washed three times with ice cold PBS. For CD4 T cell-depleted APCs, CD4 T 
cells were depleted from splenocytes as described above. Complete blocking of cell division 
was checked by inhibition of Con A-activated proliferation. To assess proliferation, 1 μCi 
[3H] methylthymidine (New England Nuclear, Newton, MA, USA) was added to each well 
18 h before harvesting. Thiodigalactoside (Sigma) was added 30 min before the stimuli. 
Recombinant mouse IL-6 (Biolegend) was added together with the stimuli. Unstimulated 
cells’ basal response ranged from 200 to 1000 cpm and was subtracted in all experiments. 
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Cytokines quantification 
IL-6 and IFN-γ levels were quantified in costimulation-assay supernatants by commercial 
ELISA (Biolegend) following manufacturer’s instructions, using recombinant cytokines-
standard curves.  
 
Intracellular IL-6 expression  
To analyze IL-6 intracellular expression, costimulation assays were performed as described 
before; and for the last 6 h, Monensin and Brefeldin A (Biolegend) were added to the 
cultures together with 1 μg/ml of LPS (Sigma). To label surface antigens, 4x106 cells were 
incubated in 100 μl of cold PBS-azide plus anti-Fcγ receptor monoclonal antibody 
(CD16/32, Clone: 93) for 20 min at 4°C. Then anti-CD11c (Clone: N418), anti-CD11b 
(Clone: M1/70), anti-B220 (Clone: RA3-6B2), anti-F4/80 (Clone: BM8), anti-CD4 (Clone: 
GK1.5), or anti-MHCII (Clone: M5/114.15.2) monoclonal antibodies conjugated to different 
fluorochromes, were added at the recommended concentrations. After 30 min, cells were 
washed and fixed with Cytofix/Cytoperm Fixation/Permeabilization Solution (BD, Franklin 
Lakes, New Jersey, USA) for 20 min at 4°C. Then, IL-6 intracellular labeling was performed 
following the manufacturer’s instructions, using anti-IL-6 (Clone: MP5-20F3). All 
monoclonal antibodies and their isotype controls were from Biolegend. IL-6-positive cells 
were determined by isotype and fluorescence minus one (FMO), negative controls. 
 
STAT3 phosphorylation  
For Western blot analysis, costimulation assays were performed for different time periods (2, 
4 and 7 h). Then, cells were washed with ice-cold PBS containing 2 mM Sodium 
orthovanadate, and lysed in cracking buffer added with protease and phosphatase inhibitor 
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PAGE and then transferred to nitrocellulose membranes (GE Healthcare Limited, Amersham 
Place, Little Chalfont, Buckinghamshire, UK). Blots were probed with anti-pSTAT3 
antibody (Cell Signaling Technology, Beverly, MA, USA), followed by goat anti-rabbit 
IRDye800 CW secondary antibody (LiCor Biosciences, Lincoln, Nebraska, USA). 
Fluorescence emission was detected with an Odyssey clx infrared imaging system, and 
signal intensity was analyzed using Image Studio Lite software (LiCor Biosciences). 
Stripped blots were re-probed with anti-STAT3 antibody (Cell Signaling Technology) and 
revealed as for pSTAT3. 
 
Flow cytometry analysis 
FlowMax cytometer PASIII (Partec, Münster, Germany) and FlowJo software (FLOWJO, 
LLC) were used throughout this work. 
 
Statistical 
ANOVA test was used; except for the analysis shown in Figure 2, where Student’s t test was 
used. p values <0.05 were considered significant. 
 
Results and Discussion  
When naïve splenocytes from DO11.10 mice are incubated with low doses of OVA323-
339 cognate peptide (OVA) in the presence of Gal-8, a synergistic CD4 T cell response 
defined as Gal-8-induced costimulation, is observed 3, 4, 21, 22. In the present work, we used 
this established and well-characterized in vitro model, to assess whether IL-6 was involved in 
the elicitation of antigen-specific responses induced by Gal-8. First, we analyzed IL-6 
secretion during Gal-8-induced costimulation. Thus, splenocytes from DO11.10 mice were 
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were determined in the supernatants by ELISA. As observed in Figure 1A, IL-6 levels were 
significantly increased in those cultures stimulated with Gal-8 alone or in combination with 
the antigen. However, no differences were recorded between antigen-stimulated and control 
cells, indicating that in this limited-antigen condition, IL-6 secretion was triggered 
specifically in the presence of Gal-8. Remarkably, the amount of IL-6 was significantly 
higher in the supernatants from Gal-8 plus OVA compared to Gal-8-alone stimulated cells, 
indicating that cognate TCR activation potentiated IL-6 secretion induced by Gal-8. 
Furthermore, IL-6 levels mirror the synergistic effect of Gal-8 on TCR activation, evidenced 
by an augmented cell proliferation and IFN-γ secretion (Figure 1B), suggesting its 
involvement in the Gal-8 costimulatory effect. It should be stressed that IL-6 level is not a 
mere reflect of cell proliferation rate, since it was also increased in Gal-8-alone treated cells, 
where proliferation was similar to basal level. Conversely, in proliferating OVA-treated cells 
the amount of secreted-IL-6 remained scarce (Figure 1A and 1B). Pre-incubation with 
thiodigalactoside, a Gal inhibitor, prevented the IL-6 increment induced by Gal-8 alone or in 
combination with the antigen, thus highlighting both Gal-8 specificity and the dependence of 
lectin-glycan interaction at the cell surface. It is well known that pathogen-recognition or 
damage-associated molecular patterns activate specific danger receptors like TLRs, to 
stimulate a range of signaling pathways including NF-kB, which enhances IL-6 production 23-
25. In this regard, we have previously demonstrated that Gal-8 induces NF-kB activation and 
IL-6 secretion in human endothelial cell line HMEC-1 26. Thus, it is plausible to consider that 
Gal-8 could directly interact with TLRs to positively regulate IL-6 transcription. In line with 
this, Gal-3 was recently described as an endogenous ligand for TLR4 that promotes 
neuroinflammation 27. Considering that TLR4 activation leads to Gal-8 secretion in 
endothelial cells, B cells and BMDCs 5, 26, 28, the presence of a positive feedback among 
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Next, we asked which cells were actually responsible for IL-6 production in response to 
Gal-8 costimulatory activity. For this purpose, splenocytes from DO11.10 mice were 
stimulated with Gal-8 plus OVA for 24 h and IL-6 intracellular levels were determined in 
different cell subpopulations by flow cytometry. As shown in Figure 2, CD11b- and CD11b+ 
conventional DCs (cDCs) and plasmacytoid DCs (pDCs) as well as macrophages, B cells and 
CD4 T cells significantly increased IL-6 production in response to Gal-8 induced-
costimulation. As expected, a large proportion of cDCs were induced to express IL-6 upon 
Gal-8 costimulation (about 23-44 %), being CD11b+ cDCs the subpopulation that expressed 
higher levels of this cytokine (MFI >10). A lower frequency (between 9 to 18%) of pDCs, 
macrophages and B cells produced IL-6 in response to Gal-8 plus OVA, and among these 
subpopulations, pDCs produced the highest level of this cytokine (MFI =10). Cytokine 
production was almost marginal in both stimulated and unstimulated CD4 T cells. These 
findings are in agreement with our previous observations where both MHCIIintCD11bhigh and 
MHChighCD11bint BMDCs subpopulations, each of which resembles cDCs and monocyte-
derived macrophages respectively, produce IL-6 in response to Gal-8 stimulation. Moreover, 
IL-6 secretion was impaired in BMDCs differentiated from Gal-8 knock out (Gal-8KO) mice, 
suggesting a physiological role for endogenous Gal-8 in the regulation of IL-6 production 5. 
Regarding B cells, and also in line with our findings, Tsai et al 28 have reported that despite 
both Gal-8 and Gal-1 play important roles in the generation of plasma cells, only Gal-8 
induces IL-6 expression on B cells. Taken together, our results indicate that Gal-8 stimulates 
different splenic subpopulation of APCs to produce and secrete IL-6 during antigen-specific 
CD4 T cell costimulation.  
To test our hypothesis by which IL-6 signaling is involved in Gal-8-dependent 
costimulatory effect during antigen recognition by specific CD4 T cells, we repeated the 
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(anti-IL-6). Notably, IL-6 neutralization inhibited Gal-8-induced costimulation, being this 
reduction specifically dependent on IL-6 blockade since no significant differences were 
observed in the presence of the isotype control antibody (Figure 3A). It should be noted that 
lymphocyte proliferation in response to OVA was independent of IL-6, since no changes in T 
cell activation were recorded when anti-IL-6 was added to antigen alone-stimulated cells. 
This observation correlated with those results described in Figure 1A and 1B where OVA-
stimulated cells proliferated and produced IFN-γ in the absence of IL-6. These results 
indicate that the costimulation induced by Gal-8, but not the antigen-response itself, depends 
on IL-6. 
The multiple functions of IL-6 are initiated upon its binding to the IL-6 receptor (IL-
6R) system, which comprises the IL-6Rα and the gp130 signal-transducing chain. Cytokine 
binding induces the homodimerization of IL-6R gp130 chains, which in turn, triggers the 
activation of downstream Janus-activated kinase (JAK)-STAT3 pathway 29. Various sets of 
IL-6-responsive genes are induced by the activation of STAT3 25. Having demonstrated that 
IL-6 is increased during Gal-8-induced costimulation of CD4 T cell response (Figure 1A), we 
next asked whether IL-6 signaling was actually triggered in the presence of Gal-8. For this 
purpose, DO11.10 mouse splenocytes were stimulated with OVA, Gal-8 or OVA plus Gal-8 
for different time-points and then the phosphorylation of STAT3 (pSTAT3) was determined 
by western-blot. As shown in Figure 3B, Gal-8 stimulation triggered STAT3 phosphorylation 
independently of the presence of the antigen after 2 h of treatment. Notably, a synergistic 
effect on the transcription factor activation was observed in the presence of both Gal-8 and 
OVA. Similar results were obtained after 4 h (data not shown) and 7 h of treatment (Figure 
3B right). Gal-8-induced pSTAT3 was inhibited in the presence of the anti-IL-6, indicating a 
tight dependence on interleukin signaling. Conversely, antigen-induced TCR activation was 
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were observed in the presence of anti-IL-6 or the isotype control. These observations are in 
agreement with the absence of IL-6 secretion and signaling in OVA alone-treated cells 
(results depicted in Figure 1A and 3A, respectively). Until here, our results strongly suggest 
that Gal-8 induces APCs to produce and secrete IL-6, which in turns signals through IL-6R in 
antigen-specific CD4 T cells to promote Gal-8 costimulatory activity. 
To further confirm our hypothesis, in which APC-derived IL-6 is responsible for the 
costimulatory activity, antigen presentation assays were performed using either Mitomycin-
C-treated or CD4 T cell-depleted splenocytes from IL-6 knock out (IL-6KO) or wild type 
(WT) mice as APCs source, co-cultured with purified CD4 T cells from OTII mice. As 
observed in Figure 3C (upper panels), Gal-8-induced costimulation was significantly 
impaired when Mitomycin-APCs were unable to produce IL-6, evidenced by cell 
proliferation (right) and IFN-γ secretion (left). Similar results were obtained when CD4 T 
cell-depleted splenocytes from IL-6KO mice were used as APCs (Figure 3C, lower panels). 
Once again, antigen-specific CD4 T cell stimulation was not affected in the absence of IL-6, 
since no differences in T cell proliferation were observed in OVA-alone stimulated cells in 
the presence of WT or IL-6-KO APCs. Additionally, this experimental design allowed 
demonstrating that antigen-specific CD4 T cells are target for IL-6-mediated effect upon Gal-
8 stimulation. Finally, to confirm that the reduction in the Gal-8 costimulatory effect was 
dependent on IL-6 deficiency, the assay depicted in Figure 3C was performed with the 
exogenous addition of recombinant IL-6. Proliferation fold increase was calculated as the 
ratio: cpm (OVA + Gal-8)/cpm (OVA) of co-cultures using IL-6KO or WT APCs. As 
depicted in Figure 3D, exogenous IL-6 restored the proliferation rate of IL-6KO APC:CD4 T 
cell co-cultures, demonstrating that the presence of IL-6 was sufficient to rescue Gal-8-
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produce IL-6, which signaling synergizes the TCR activation during antigen recognition on 
CD4 T cells, resulting in the Gal-8 costimulatory activity.  
In summary, the in vitro model used throughout this work allowed us to evidence the 
participation of IL-6 signaling in Gal-8-induced costimulation during the elicitation of the 
antigen-specific CD4 T cell response. Since IL-6 is a key cytokine involved in the 
differentiation of Tfh cells and germinal center formation, our findings support a plausible 
mechanism by which Gal-8 stimulates the antigen-specific protective humoral response 
previously observed in a viral vaccine model 5. Interestingly, aged CD4 T cells require higher 
levels of IL-6 produced during the CD4 T cell:APC cognate interaction compared to young 
CD4 T cells, to effectively induce IL-6 signaling, read out as IgG antibody production 10, 18. 
Gal-8, by activating IL-6 production from APCs during cognate interaction with naïve CD4 T 
cells, could circumvent the insufficient response of aged cells, thus becoming an attractive 
candidate to add in vaccines formulation for the compromised populations.  
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Figure Legends  
Figure 1. Gal-8 induces IL-6 secretion during costimulation of antigen-specific CD4 T 
cell response A) Quantification of IL-6 by ELISA in supernatants from Gal-8-induced 
costimulation cultures. B) Quantification of IFNJ by ELISA in supernatants (left) and cell 
proliferation (right) of Gal-8-induced costimulation cultures. For all assays, splenocytes 
(3x105 cells) from DO11.10 mice were cultured for 48 h in the presence of 0.1 μg/ml of 
OVA323–339 peptide (OVA), and/or 0.2 μM of Gal-8. Thiodigalactoside (TDG, 30 mM) was 
added 30 min before the stimulus. TDG had no effect on OVA response (not shown). ND, not 
detected. Depicted assays are representative of at least three independent experiments and 
were carried out, each time, with different recombinant protein preparations. **p<0.01; 
***p<0.001; ****p<0.0001. 
 
Figure 2. APCs produce IL-6 during Gal-8-induced costimulation. IL-6 intracellular 
expression was determined by flow cytometry during Gal-8-induced costimulation. 
Splenocytes (4x106) from DO11.10 mice were cultured for 24 h in the presence of 0.1 μg/ml 
of OVA323–339 peptide and 0.2 μM of Gal-8 (OVA + Gal-8), or left untreated (Control). Cells 
were labeled with specific monoclonal antibodies for surface antigens (MHCII, CD11b, 
CD11c, F4/80, CD4 and B220) and for intracellular IL-6. IL-6+ population is box enfolded in 
the counter plots. Bars indicate percentage of IL-6+ cells and the mean fluorescence intensity 
(MFI). FSC, forward side scatter. Depicted assays are representative of two independent 
experiments and were carried out, each time, with different recombinant protein preparations. 
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Figure 3. Gal-8-induced CD4 T cell costimulation is dependent on IL-6. A) IL-6 
neutralization. Splenocytes (3x105 cells) from DO11.10 mice were cultured in the presence of 
0.1 μg/ml of OVA323–339 peptide (OVA), and/or 0.2 μM of Gal-8, in the presence or absence 
of IL-6 neutralizing monoclonal antibody (anti-IL-6) or isotype control (Iso). After 48 h, 
proliferation was assessed. B) STAT3 activation. Splenocytes (9x106 cells) from DO11.10 
mice were stimulated for 2 or 7 h with 0.1 μg/ml of OVA, and/or 0.2 μM of Gal-8, in the 
presence or absence of IL-6 neutralizing monoclonal antibody (anti-IL-6) or isotype control 
(Iso). For positive control, cells were incubated for 15 min with 100 ng/ml of recombinant 
IL-6 (rIL-6). Protein expression levels of pSTAT3 and total STAT3 were detected by western 
blot analysis. Bars depict pSTAT/STAT3 fluorescence signal ratio. C) Gal-8-induced 
costimulation in the presence of IL-6-deficient APCs. IL6KO and C57BL/6J mice-derived 
APCs (2x105): Mitomycin-APCs (upper panels) or CD4 depleted-APCs (lower panels), were 
co-cultured with CD4 T cells (1X105) purified from OTII mice, in the presence of 0.05-0.1 
μg/ml of OVA, and/or 0.2 μM of Gal-8. After 48 h, cell proliferation (right), and 
quantification of IFNJ by ELISA in supernatants (left) were assessed. D) Same as C) with 
Mitomycin-APCs, and with addition of 5 ng/ml of rIL-6 to the co-cultures containing IL-
6KO APCs. Fold increase was calculated as the cpm (OVA+Gal-8)/cpm (OVA) ratio. 
Depicted assays are representative of three (A) and two (B, C and D) independent 
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